The Centers for Medicare & Medicaid Services (CMS) has announced the discontinuation of the Part D Premium Stabilization Demonstration, a program that subsidized Medicare drug plans. This subsidy, created by the Biden administration and later scaled back by the Trump administration, aimed to cushion the impact of the Inflation Reduction Act's changes to Medicare Part D by lowering national base premiums and capping annual increases. Despite its success in keeping premiums lower and enrollment higher than anticipated, the program cost the government approximately $9.8 billion over two years. CMS states the subsidy is ending because insurers now have sufficient experience to price their products without federal assistance, though analysts express concern about the proportional impact of losing the subsidy on average monthly premiums. AI
RANK_REASON Policy change impacting millions of Medicare beneficiaries with a clear financial impact. [lever_c_demoted from significant: ic=1 ai=0.0]
- Biden Administration
- Centers for Medicare and Medicaid Services
- Inflation Reduction Act of 2022
- Kaiser Family Foundation
- Medicare
- Medicare Payment Advisory Commission
- Mehmet Oz
- Part D Premium Stabilization Demonstration
- The Wall Street Journal
- Trump administration
- United States Government Accountability Office
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
